DOXGX | LBWCX | DOXGX / LBWCX | |
Total Expense Ratio | 0.41 | 1.90 | 22% |
Annual Report Gross Expense Ratio | 0.46 | 1.91 | 24% |
Fund Existence | 3 years | 15 years | - |
Gain YTD | 3.684 | 1.767 | 209% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 88.5M | 128,814% |
Annual Yield % from dividends | 1.49 | 0.72 | 208% |
Returns for 1 year | 6.03 | 1.86 | 323% |
Returns for 3 years | 28.44 | 13.16 | 216% |
Returns for 5 years | N/A | 32.08 | - |
Returns for 10 years | N/A | 8.53 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VTC | 76.17 | -0.38 | -0.50% |
Vanguard Total Corporate Bond ETF | |||
DGRW | 81.95 | -0.77 | -0.93% |
WisdomTree US Quality Dividend Gr ETF | |||
EELV | 25.85 | -0.26 | -1.00% |
Invesco S&P Emerging Markets Low Vol ETF | |||
XUSP | 39.98 | -0.58 | -1.44% |
Innovator Uncapped Accelerated US Eq ETF | |||
XPH | 41.43 | -0.63 | -1.50% |
SPDR® S&P Pharmaceuticals ETF |